126 related articles for article (PubMed ID: 22768449)
1. Fenofibrate, a peroxisome proliferator-activated receptor alpha, improves myocardial capillary density in diabetic rats.
Salehi E; Khazaei M
J Pak Med Assoc; 2012 Mar; 62(3 Suppl 2):S9-12. PubMed ID: 22768449
[TBL] [Abstract][Full Text] [Related]
2. Role of fenofibrate in restoring angiogenesis in diabetic and control hind limb ischemic rats.
Salehi E; Khazaei M; Rashidi B
Gen Physiol Biophys; 2012 Sep; 31(3):255-60. PubMed ID: 23047938
[TBL] [Abstract][Full Text] [Related]
3. PPARα Agonist Stimulated Angiogenesis by Improving Endothelial Precursor Cell Function Via a NLRP3 Inflammasome Pathway.
Deng Y; Han X; Yao Z; Sun Y; Yu J; Cai J; Ren G; Jiang G; Han F
Cell Physiol Biochem; 2017; 42(6):2255-2266. PubMed ID: 28817808
[TBL] [Abstract][Full Text] [Related]
4. The combined strategy with PPARα agonism and AT₁ receptor antagonism is not superior relative to their individual treatment approach in preventing the induction of nephropathy in the diabetic rat.
Bishnoi HK; Mahadevan N; Balakumar P
Pharmacol Res; 2012 Oct; 66(4):349-56. PubMed ID: 22796657
[TBL] [Abstract][Full Text] [Related]
5. PPAR-alpha agonist fenofibrate induces renal CYP enzymes and reduces blood pressure and glomerular hypertrophy in Zucker diabetic fatty rats.
Zhao X; Li LY
Am J Nephrol; 2008; 28(4):598-606. PubMed ID: 18277067
[TBL] [Abstract][Full Text] [Related]
6. [Fenofibrate improves energy metabolism and attenuates isoproterenol induced acute myocardial ischemic injury in rats via PPAR alpha activation].
Yuan J; Wu J; Han ZG
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Sep; 36(9):847-50. PubMed ID: 19102873
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: possible neuroprotective mechanisms.
Bhateja DK; Dhull DK; Gill A; Sidhu A; Sharma S; Reddy BV; Padi SS
Eur J Pharmacol; 2012 Jan; 674(1):33-43. PubMed ID: 22056833
[TBL] [Abstract][Full Text] [Related]
8. Treatment of experimental autoimmune uveoretinitis with peroxisome proliferator-activated receptor α agonist fenofibrate.
Osada M; Sakai T; Kuroyanagi K; Kohno H; Tsuneoka H
Mol Vis; 2014; 20():1518-26. PubMed ID: 25489225
[TBL] [Abstract][Full Text] [Related]
9. Targeting apoptosis in the heart of streptozotocin-induced diabetic rats.
Baraka A; AbdelGawad H
J Cardiovasc Pharmacol Ther; 2010 Jun; 15(2):175-81. PubMed ID: 20133494
[TBL] [Abstract][Full Text] [Related]
10. PPAR-α Agonist Fenofibrate Ameliorates Oxidative Stress in Testicular Tissue of Diabetic Rats.
Yaribeygi H; Mohammadi MT; Jamialahmadi T; Sahebkar A
Crit Rev Eukaryot Gene Expr; 2020; 30(2):93-100. PubMed ID: 32558488
[TBL] [Abstract][Full Text] [Related]
11. Pioglitazone prevents capillary rarefaction in streptozotocin-diabetic rats independently of glucose control and vascular endothelial growth factor expression.
Ashoff A; Qadri F; Eggers R; Jöhren O; Raasch W; Dendorfer A
J Vasc Res; 2012; 49(3):260-6. PubMed ID: 22456468
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor α protects capillary pericytes in the retina.
Ding L; Cheng R; Hu Y; Takahashi Y; Jenkins AJ; Keech AC; Humphries KM; Gu X; Elliott MH; Xia X; Ma JX
Am J Pathol; 2014 Oct; 184(10):2709-20. PubMed ID: 25108226
[TBL] [Abstract][Full Text] [Related]
13. Fenofibrate improves renal function by amelioration of NOX-4, IL-18, and p53 expression in an experimental model of diabetic nephropathy.
Yaribeygi H; Mohammadi MT; Rezaee R; Sahebkar A
J Cell Biochem; 2018 Sep; 119(9):7458-7469. PubMed ID: 29761900
[TBL] [Abstract][Full Text] [Related]
14. Fenofibrate A peroxisome proliferator activated receptor-α agonist treatment ameliorates Concanavalin A-induced hepatitis in rats.
Mohamed DI; Elmelegy AA; El-Aziz LF; Abdel Kawy HS; El-Samad AA; El-Kharashi OA
Eur J Pharmacol; 2013 Dec; 721(1-3):35-42. PubMed ID: 24140572
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic Role of PPARα Downregulation in Corneal Nerve Degeneration and Impaired Corneal Sensitivity in Diabetes.
Matlock HG; Qiu F; Malechka V; Zhou K; Cheng R; Benyajati S; Whelchel A; Karamichos D; Ma JX
Diabetes; 2020 Jun; 69(6):1279-1291. PubMed ID: 32213513
[TBL] [Abstract][Full Text] [Related]
16. Activation of peroxisome proliferator-activated receptor-alpha by fenofibrate prevents myocardial dysfunction during endotoxemia in rats.
Jozefowicz E; Brisson H; Rozenberg S; Mebazaa A; Gelé P; Callebert J; Lebuffe G; Vallet B; Bordet R; Tavernier B
Crit Care Med; 2007 Mar; 35(3):856-63. PubMed ID: 17255874
[TBL] [Abstract][Full Text] [Related]
17. Coronary flow velocity reserve is improved by PPAR-α agonist fenofibrate in patients with hypertriglyceridemia.
Wang G; He L; Liu J; Yu J; Feng X; Li F; Hao Y; Mao J; Hong T; Chen AF; Wang X
Cardiovasc Ther; 2013 Jun; 31(3):161-7. PubMed ID: 22280018
[TBL] [Abstract][Full Text] [Related]
18. Fenofibrate reduces cardiac remodeling and improves cardiac function in a rat model of severe left ventricle volume overload.
Dhahri W; Couet J; Roussel É; Drolet MC; Arsenault M
Life Sci; 2013 Jan; 92(1):26-34. PubMed ID: 23142240
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor-α agonists protect cortical neurons from inflammatory mediators and improve peroxisomal function.
Gray E; Ginty M; Kemp K; Scolding N; Wilkins A
Eur J Neurosci; 2011 Apr; 33(8):1421-32. PubMed ID: 21375604
[TBL] [Abstract][Full Text] [Related]
20. Fenofibrate ameliorates cardiac hypertrophy by activation of peroxisome proliferator-activated receptor-α partly via preventing p65-NFκB binding to NFATc4.
Zou J; Le K; Xu S; Chen J; Liu Z; Chao X; Geng B; Luo J; Zeng S; Ye J; Liu P
Mol Cell Endocrinol; 2013 May; 370(1-2):103-12. PubMed ID: 23518069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
